NM_206808.5:c.50C>T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_206808.5(CLYBL):c.50C>T(p.Ala17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,482,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A17T) has been classified as Uncertain significance.
Frequency
Consequence
NM_206808.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000695 AC: 105AN: 151182Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000434 AC: 4AN: 92270 AF XY: 0.0000192 show subpopulations
GnomAD4 exome AF: 0.0000473 AC: 63AN: 1331088Hom.: 0 Cov.: 35 AF XY: 0.0000289 AC XY: 19AN XY: 656642 show subpopulations
GnomAD4 genome AF: 0.000694 AC: 105AN: 151294Hom.: 0 Cov.: 31 AF XY: 0.000568 AC XY: 42AN XY: 73938 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.50C>T (p.A17V) alteration is located in exon 1 (coding exon 1) of the CLYBL gene. This alteration results from a C to T substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at